A detailed history of Integrated Investment Consultants, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 114,032 shares of ABT stock, worth $13.2 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
114,032
Previous 8,130 1302.61%
Holding current value
$13.2 Million
Previous $844,000 1440.28%
% of portfolio
0.29%
Previous 0.25%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $10.6 Million - $12.5 Million
105,902 Added 1302.61%
114,032 $13 Million
Q1 2024

Apr 18, 2024

SELL
$109.52 - $120.96 $55,636 - $61,447
-508 Reduced 5.88%
8,130 $924,000
Q4 2023

May 28, 2024

BUY
$90.19 - $110.4 $811 - $993
9 Added 0.11%
8,123 $894,000
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $811 - $993
9 Added 0.1%
8,638 $950,000
Q3 2023

May 28, 2024

SELL
$95.53 - $114.62 $1,528 - $1,833
-16 Reduced 0.2%
8,114 $785,000
Q3 2023

Oct 17, 2023

SELL
$95.53 - $114.62 $19,965 - $23,955
-209 Reduced 2.36%
8,629 $835,000
Q2 2023

Jul 18, 2023

BUY
$100.78 - $112.29 $7,356 - $8,197
73 Added 0.83%
8,838 $963,000
Q1 2023

Jul 18, 2023

SELL
$96.86 - $114.01 $4,358 - $5,130
-45 Reduced 0.51%
8,793 $890,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $45,913 - $53,864
483 Added 5.83%
8,765 $962,000
Q3 2022

Nov 21, 2022

BUY
$96.76 - $112.03 $19,545 - $22,630
202 Added 2.5%
8,282 $801,000
Q2 2022

Jul 19, 2022

SELL
$102.07 - $123.37 $69,101 - $83,521
-677 Reduced 7.73%
8,080 $878,000
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $79,243 - $96,632
-695 Reduced 7.35%
8,757 $1.04 Million
Q4 2021

Jan 10, 2022

SELL
$115.53 - $141.46 $157,813 - $193,234
-1,366 Reduced 12.63%
9,452 $1.33 Million
Q3 2021

Oct 28, 2021

BUY
$116.66 - $129.06 $1,516 - $1,677
13 Added 0.12%
10,818 $1.28 Million
Q2 2021

Jul 21, 2021

BUY
$105.79 - $124.53 $147,788 - $173,968
1,397 Added 14.85%
10,805 $1.25 Million
Q1 2021

Apr 20, 2021

SELL
$108.84 - $128.23 $130,281 - $153,491
-1,197 Reduced 11.29%
9,408 $1.13 Million
Q4 2020

Feb 09, 2021

SELL
$105.0 - $114.42 $23,100 - $25,172
-220 Reduced 2.03%
10,605 $1.16 Million
Q3 2020

Oct 26, 2020

SELL
$91.64 - $111.29 $4,582 - $5,564
-50 Reduced 0.46%
10,825 $1.18 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $8,575 - $10,976
-112 Reduced 1.02%
10,875 $994,000
Q1 2020

May 22, 2020

SELL
$62.82 - $91.86 $73,939 - $108,119
-1,177 Reduced 9.68%
10,987 $867,000
Q4 2019

Jan 29, 2020

SELL
$78.51 - $87.4 $21,747 - $24,209
-277 Reduced 2.23%
12,164 $1.06 Million
Q2 2019

Jul 16, 2019

BUY
$72.88 - $85.0 $25,508 - $29,750
350 Added 2.89%
12,441 $1.05 Million
Q1 2019

Apr 26, 2019

SELL
$66.22 - $80.06 $167,470 - $202,471
-2,529 Reduced 17.3%
12,091 $967,000
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $1.89 Million - $2.09 Million
-32,870 Reduced 69.21%
14,620 $892,000
Q2 2018

Aug 01, 2018

BUY
$57.57 - $63.54 $1.89 Million - $2.09 Million
32,870 Added 224.83%
47,490 $925,000
Q1 2018

Apr 12, 2018

BUY
$56.27 - $63.62 $7,708 - $8,715
137 Added 0.95%
14,620 $876,000
Q3 2017

Oct 26, 2017

BUY
$48.06 - $53.64 $696,052 - $776,868
14,483
14,483 $773,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Integrated Investment Consultants, LLC Portfolio

Follow Integrated Investment Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.